Medical Device Network on MSN
Masimo secures FDA approval for OIRD detection on wearable patient monitor
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...
The FDA clearance allows the W1 wearable to be sold for both over-the-counter and prescription use—making it the first SpO2-tracking smartwatch to carry both indications in the U.S., per Masimo.
Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
GE Healthcare and Masimo have announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile wireless and wearable patient monitoring ...
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results